New England School of Homeopathy

Herscu Laboratory & Consulting

Herscu Laboratory is a multi-disciplinary collaborative community devoted to high quality research. Our aim is to elucidate underlying principles and develop effective applications in both medicine and education. Areas of particular interest include pediatrics, neurology, immunology, oncology, veterinary medicine, biology of complex systems, personalized medicine, integrative medicine, and optimizing education for all kinds of learners.

In addition to our core staff of researchers, we work in conjunction with a number of other individuals, research organizations, private companies, and schools. Research at Herscu Laboratory spans a wide range of methodologies from primary clinical trials and basic laboratory research to literature review and data mining. By bringing together cutting-edge thinkers from across the sciences, we take advantage of the power of interdisciplinary thinking and research.

The general research approach at Herscu Laboratory is driven by the integration of scientific ideas across related fields of biology and medicine, with the goal of generating models of understanding that can influence research, clinical application, and education. Multi-disciplinary research is currently on-going in the following areas:

Pediatrics
Neurology
Immunology
Oncology
Pharmaceutical Research and Development
Public Health
Military Medical Applications
Education
Veterinary Medicine
Biology of Complex Systems
Complementary and Alternative Medicine (CAM)
Evidenced-based Research in Classical Homeopathy

Example of Clinical Trial Studies Published:

Herscu P, Handen BL, Arnold LE, Snape MF, Bregman JD, Ginsberg L, Hendren R, Kolevzon A, Melmed R, Mintz M, Minshew N, Sikich L, Attalla A, King B, Owley T, Childress A, Chugani H, Frazier J, Cartwright C, Murphy T; Autism Speaks Autism Clinical Trials Network. The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder. J Autism Dev Disord. 2019 Jul 2

Igonin AA, Protsenko DN, Galstyan GM, Vlasenko AV, Khachatryan NN, Nekhaev IV, Shlyapnikov SA, Lazareva NB, Herscu P. C1-Esterase Inhibitor Infusion Increases Survival Rates for Patients With Sepsis. Crit Care Med. 2012 Mar;40(3):770-7.

Bluestein H, Hoover TA, Banerji A, Camargo C, Reshef A, Herscu P. Angiotensin-Converting Enzyme Inhibitor-induced Angioedema in a Community Hospital Emergency Department. Annals of Allergy, Asthma, and Immunology. 2009 Dec;103(6):502-7.

Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P. Angiotensin Converting Enzyme Inhibitor Induced Angio-Oedema: A Review of the Pathophysiology and Risk Factors. Clin Exp Allergy. 2010 Jan;40(1):50-61.

Herscu P, Hoover TA, Randolph A. Clinical Prediction Rules: New Opportunities for Pharma. Drug Discovery Today. 2009 Dec;14(23-24):1143-9.

Kirkby R, Herscu P. Homeopathic Trial Design in Influenza Treatment. Homeopathy. 2010 Jan;99(1):69-75.

Kirkby R, Calabrese C, Kaltman L, Monnier J, Herscu P. Methodological Considerations for Future Controlled Influenza Treatment Trials in Complementary and Alternative Medicine. Journal of Complementary and Alternative Medicine. 2010 Mar;16(3):275-83.